Current Pharmaceutical Biotechnology

Journal Title：Current Pharmaceutical Biotechnology

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include:

DNA/protein engineering and processing

Synthetic biotechnology

Omics (genomics, proteomics, metabolomics and systems biology)

Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)

Drug delivery and targeting

Nanobiotechnology

Molecular pharmaceutics and molecular pharmacology

Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)

Pharmacokinetics and pharmacodynamics

Applied Microbiology

Bioinformatics (computational biopharmaceutics and modeling)

Environmental biotechnology

Regenerative medicine (stem cells, tissue engineering and biomaterials)

Translational immunology (cell therapies, antibody engineering, xenotransplantation)

Industrial bioprocesses for drug production and development

Biosafety

Biotech ethics

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

《当代制药生物技术》旨在涵盖制药生物技术领域所有最新和杰出的发展。该期刊的每一期都包括及时深入的评论、原创研究文章和该领域领导者撰写的信函，涵盖制药生物技术科学领域的一系列当前主题。欢迎邀请和主动撰写评论文章。该期刊鼓励投稿描述药物发现和药理应用界面的研究，涉及体外调查和临床前或临床研究。该期刊范围内的科学领域包括与制药科学和生物技术相关的药物化学、生物化学和遗传学、分子和细胞生物学以及聚合物和材料科学。此外，该期刊还考虑与制药相关的食品化学的综合研究和研究进展。感兴趣的领域包括：

DNA/蛋白质工程和加工

合成生物技术

组学（基因组学、蛋白质组学、代谢组学和系统生物学）

治疗生物技术（基因治疗、肽抑制剂、酶）

药物输送和靶向

纳米生物技术

分子药剂学和分子药理学

分析生物技术（生物传感、检测生物分析物的先进技术）

药代动力学和药效学

应用微生物学

生物信息学（计算生物药剂学和建模）

环境生物技术

再生医学（干细胞、组织工程和

生物材料

转化免疫学（细胞疗法、抗体工程、异种移植）

药物生产和开发的工业生物过程

生物安全

生物技术伦理

欢迎刊登关于关键主题的特刊，提供有关前沿研究领域和技术进步的最新综合信息。

《当代制药生物技术》是一本重要的期刊，适合希望随时了解最新和最重要发展的学术、临床、政府和制药科学家。

Current Pharmaceutical Biotechnology创刊于2000年，由Bentham Science Publishers B.V.出版商出版，收稿方向涵盖医学 - 生化与分子生物学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 一般,3-6周 ，影响因子指数2.2，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。